
Mar 2, 2025, 10:50
Myeloma Paper of the Day, March 2nd, suggested by Robert Orlowski
Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Retrospective study of salvage treatments after covalent BTKi failure in Waldenstrom macroglobulinemia patients finds PFS of 5.8, 5.0, 6.9 and 3.9 months for chemo/immunotherapy, proteasome inhibitor, venetoclax and ncBTKi.”
Authors: Anna Maria Frustaci, Arianna Zappaterra, Andrea Galitzia, Francesco Piazza, Alessandra Tedeschi et al.
More posts featuring Robert Orlowski.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 17:49
Apr 1, 2025, 17:18
Apr 1, 2025, 16:18